SUNPHARMA Stock View

Sun Pharmaceutical Industries Ltd

SUNPHARMA Stock View

(NSE)

Trade

₹ 1,146.15

-12.05 | -1.05

Market Cap ₹( Cr.)
2,749,998.00

Proj. P/E (x)
29.40

Proj. P/BV (x)
4.56

Proj. ROE (%)
15.48

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)
488,066.24

BUY

Last Updated On.
17-Sep-2023

 

Copy Link

Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company. The Company is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and active pharmaceutical ingredients (APIs). It produces a comprehensive, diverse and complementary portfolio of generic and specialty medicines targeting a wide spectrum of chronic and acute treatments. The Company's vertically integrated network enables it to produce a wide range of pharmaceuticals, including oncology, hormones, peptides, and steroidal drugs. The Company also has a product portfolio in RoW markets, including injectables, hospital products and retail products. It offers a variety of dosage forms, including orals, creams, ointments, injectables, sprays, and liquids. Its marketed specialty portfolio includes Ilumya/ Ilumetri, Winlevi, Levulan Kerastick + BLU-U, Absorica LD, Odomzo, Cequa, Bromsite, Xelpros, Yonsa, Sezaby and Sprinkle portfolio.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data